[1]袁志斌.获得FDA批准的放射性药物[J].国际放射医学核医学杂志,2000,24(4):161-163.
　YUAN Zhi-bin.FDA approved radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(4):161-163.
点击复制

获得FDA批准的放射性药物(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
24
期数:
2000年第4期
页码:
161-163
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
FDA approved radiopharmaceuticals
作者:
袁志斌
200233 上海, 上海市第六人民医院核医学科
Author(s):
YUAN Zhi-bin
Department of Nuclear Medicine Shanghai 6th People’s Hospital, Shanghai 200233, China
关键词:
放射性药物; 美国食品与药物管理局; 监控与管理
Keywords:
radiopharmaceutical; contro and mnagement; food and drug administration
分类号:
R817.4
摘要:
FDA即美国食品与药物管理局,其主要职能是确保食物、化妆品、药品、医疗设备、放射性产品如微波炉、动物用的食物与药品的安全与可靠,放射性药物也在其管理之列。文章综述了有关FDA的基本情况以及得到FDA批准的显像与治疗用放射性药物,了解这一领域的发展动向。
Abstract:
FDA is the abbreviation of American Food and Drug Administration. Its main job is assuring the safety and reliability of the food, cosmetics, medicines, medical devices and radiation emitting products such as microwave oven, the food and medicine for animals. Radiopharmaceuticals are also under its management. In this review, the basic information of FDA and FDA approved radiopharmaceuticlas are introduced.

参考文献/References:

[1] Frost and Sullivan. Future of nuclear medicine, Part 1:Marketing research forecasts[J]. J Nucl Med, 1998, 39(2):27N.
[2] Frost and Sullivan. Future of nucledr medicint, Part 2:Assessment of the U. S. diagnostic radiopharmaceuticals market (2001~2020)[J]. J Nucl Med, 1998, 39(3):20N.
[3] Frost and Sullivan. Future of nuclear medicine, Part 3:Assessment of the U. S. therapeutic radiopharmaceuticals market (2001~2020)[J]. J Nucl Med, 1998, 39(7):14N.

相似文献/References:

[1]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
　Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[2]甘红梅,乔晋萍,孔爱英,等.正电子放射性显像剂代谢及其研究方法进展[J].国际放射医学核医学杂志,2010,34(2):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
　GAN Hong-mei,QIAO Jin-ping,KONG Ai-ying,et al.The progress on researching method and metabolism of positron radiopharmaceutical[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):65.[doi:10.3760/cma.j.issn.1673-4114.2010.02.001]
[3]顾涛颖,石洪成.放射性药物治疗肿瘤骨转移性骨痛的作用[J].国际放射医学核医学杂志,2010,34(2):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
　GU Tao-ying,SHI Hong-cheng.The use of radiopharmaceuticals for metastatic bone pain in cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):88.[doi:10.3760/cma.j.issn.1673-4114.2010.02.006]
[4]周雪,乔晋萍,孔爱英,等.受体结合实验及其在放射性显像剂研究中的应用进展[J].国际放射医学核医学杂志,2010,34(6):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
　ZHOU Xue,QIAO Jin-ping,KONG Ai-ying,et al.Progress on the application of ligand receptor binding assays in radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):321.[doi:10.3760/cma.j.issn.1673-4114,2010.06.001]
[5]彭添兴,吴华.18F-氟脱氧葡萄糖以外新型PET肿瘤显像剂[J].国际放射医学核医学杂志,2007,31(1):9.
　PENG Tian-xing,WU Hua.New type PET imaging agent excluding 18F-fluorodeoxyglucose in oncology[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):9.
[6]范我.用于肿瘤治疗的放射性药物[J].国际放射医学核医学杂志,2004,28(1):21.
　FAN Wo.Radiopharmaceuticals for tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):21.
[7]陈璟,吴华.核素炎症显像的研究进展[J].国际放射医学核医学杂志,2003,27(3):107.
　CHEN Jing,WU Hua.The development of radionuclide imaging of infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):107.
[8]杨建权,李晔,张现忠.基于小分子肽的放射性药物[J].国际放射医学核医学杂志,2003,27(4):157.
　YANG Jian-quan,LI Ye,ZHANG Xian-zhnng.Peptide as carrier for diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):157.
[9]谷晓云.核医学诊断操作中的亚细胞水平吸收剂量及其生物效应[J].国际放射医学核医学杂志,2001,25(4):165.
　GU Xiao-yun.Cellular dosimetry and biological conseuences caused by diagnostic nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):165.
[10]弓全胜,夏振民.放射性药物的给药后归宿[J].国际放射医学核医学杂志,1998,22(4):167.

备注/Memo

备注/Memo:
收稿日期:2000-04-11。
作者简介:袁志斌(1969-),男,上海市人,上海市第六人民医院核医学科主管技师,理学学士,主要从事放射性药物的研究。
更新日期/Last Update: 1900-01-01